Surmodics Inc expected to post a loss of 38  cents a share - Earnings Preview

SurModics

25/07/2022 19:33

* Surmodics Inc  SRDX.OQ   SRDX.O  is expected to show a
rise in
quarterly revenue when it reports  results on July 27. 
    * The Eden Prairie Minnesota-based  company is expected to
report 
a 5.5% increase in revenue to $25.194 million from $23.87
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Surmodics Inc is
for a
loss of 38 cents per share. For the same quarter last year, the
company reported a loss of 17 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Surmodics
Inc is
$68​, above​ its last closing price of $38.41. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.35       -0.34      -0.22     Beat    35.3
 Dec. 31 2022  -0.31       -0.31      -0.13     Beat    58.5
 Sep. 30 2021  -0.25       -0.25      -0.10     Beat    60​
 Jun. 30 2021  -0.15       -0.17      -0.17     Met     -2
 ​​Mar.        0.66        0.63       0.62      Missed  -2.1
 31 2021                                                
 Dec. 31 2020  -0.08       -0.09      0.02      Beat    122.2​
 Sep. 30 2020  -0.07       -0.08      -0.18     Missed  -125
 Jun. 30 2020  0.17        0.19       0.21      Beat    8.6
 This summary was machine generated July 25 at 18:32 GMT.  All
figures in US dollars  unless otherwise stated